VBI Vaccines Inc. (Nasdaq: VBIV and TSX: VBV) (“VBI”) is scheduled to present at the Jefferies 2016 Healthcare Conference on Friday, June 10 at 2:30 PM ET. The event is being held at the Grand Hyatt New York in New York City.

During the presentation, Jeff Baxter, VBI’s President and CEO, will provide an overview of VBI and its platform technologies, and will summarize recent developments in the company’s pipeline of vaccine candidates. Mr. Baxter will also discuss VBI’s recently completed merger with SciVac Therapeutics and Sci-B-Vac™, a third-generation licensed hepatitis B vaccine.At the time of the presentation, a live audio webcast will be available at: http://wsw.com/webcast/jeff97/vbiv

VBI recommends registering for the webcast at least ten minutes prior to the start of the presentation to ensure timely access. The webcast and presentation will also be archived for 90 days following the event.

The Jefferies Healthcare Conference features an extensive range of public and private healthcare companies across the biopharmaceuticals, life sciences, and healthcare services sectors. For additional information, or to schedule a one-on-one meeting with VBI management, please contact ir@vbivaccines.com.

Event Details